/Investor DB

F-Prime Capital — 2018 Investments

16 investments dated 2018 · listed companies and verified rows first · show all

Beam Therapeuticsbeamtx.comin𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesForesite CapitalGV (Google Ventures)HongShan Capital Group+2 more

Generation Biogenerationbio.comFeb 2018SEC filingmedium confidence

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)

BoardJason Rhodes(Director)inAnthony Quinn(Director)

Board seatCatherine Stehman-Breen· per SEC Form D · $100.4M raise · filed Mar 2018

Co-investorsAtlas VentureForesite CapitalWellington ManagementCasdin CapitalDeerfield Management CompanyFidelity Investments+1 more

Real Estate Equity Exchangeunisonim.comMay 2018SEC filingmedium confidence

Unison Investment Management (UnisonIM) is a registered investment adviser that builds and manages institutional equity and credit strategies giving exposure to U.S. residential housing and home price appreciation.

FintechPropTechSan Francisco, US

Thomas Sponholtz(Founder, CEO & Chairman)John Martinez(Director)Edgar Green(Director)James Riccitelli(Executive Officer, Director)Douglas H. Lowrey(Director)Matthew O'Hara(Chief Investment Officer)

Board seatDavid Jegen· per SEC Form D · $40M raise · filed Jun 2018

Centivocentivo.cominSeries A · Jul 2018 · $34M

Centivo is a primary-care-centered health plan administrator for self-funded employers, sold through benefits brokers and consultants.

Digital HealthHealthtechInsurTechBuffalo, US

Alan Cohen(Founder)inAshok Subramanian(Chief Executive Officer)inStuart Roth(Founder)in

Co-investorsAlumni VenturesB Capital GroupB4 CapitalBain Capital VenturesBasecamp FundCox Enterprises+7 more

Genomicsgenomics.cnSeries B · Dec 2018 · $9M

BGI (Huada) is a genomics research and services organization offering clinical genetic testing, scientific research services, forensic/judicial testing, and sequencing instruments.

BiotechDeep TechDigital Health

Wang Jian(Founder)

Co-investorsForesite CapitalGreen Pine Capital Partners

Hua Medicinehuamedicine.comMar 2018 · $117.4M

Shanghai-based, HKEX-listed drug developer commercializing dorzagliatin, the first approved glucokinase activator for type 2 diabetes.

Li Chen(Founder)

Co-investorsARCH Venture PartnersVenrock6 Dimensions CapitalAlly Bridge GroupBlue Pool CapitalEight Roads Ventures+2 more

Iora Health𝕏May 2018 · $100Macquired by One Medical

Iora Health was a primary care company focused on value-based care for Medicare-eligible seniors, operating clinics with a team-based model including health coaches.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

RUSHIKA FERNANDOPULLE(Executive Officer, Director)inCHRISTOPHER J. MCKOWN(Executive Officer, Director)DAVID FIELDING(Executive Officer)ALEXANDER PACKARD(Executive Officer)inDAVID JUDGE(Executive Officer)

BoardSTEPHEN KNIGHT(Director)in

Co-investors.406 VenturesDag VenturesFlare Capital PartnersGV (Google Ventures)Lifeforce CapitalMaverick Ventures+10 more

Kyruuskyruushealth.cominApr 2018 · $10M

Kyruus Health provides a provider and location data management solution that consolidates, cleanses, and standardizes health systems' data into a single source, using AI and automation to maintain accuracy.

Data & InfrastructureDigital HealthHealthtechSaaSBoston, US

Julie Yoo(Executive Officer, Director)inGraham Gardner(Founder)in

BoardRobert Paull(Director)inRobert Higgins(Director)Bryan Roberts(Director)Donald Trigg(Director)

Co-investorsFrancisco PartnersTRANSFORMATION CAPITALVenrockHighland Capital PartnersLux CapitalMcKesson Ventures+1 more

Madaketmadakethealth.comin𝕏Jul 2018

Madaket operates a SOC 2 Type 2-compliant platform that ingests, standardizes, validates, and synchronizes provider data for the healthcare provider–payer ecosystem.

Data & InfrastructureDigital HealthHealthtechSaaSCambridge, US

James P. Dougherty(Executive Officer, Director)Ted Achtem(Chief Data Officer)inMegan Schmidt(CEO)inJerry Held(Director)Archibald Cox(Director)Jeannine Dahling(Chief Operating Officer)

Co-investorsQiming Venture Partners USARaptor GroupWaterline VenturesExperian VenturesQiming Venture Partners

Metcelametcela.comSep 2018

Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development.

BiotechHealthtechMedical Devices

Co-investorsBeyond Next VenturesOSAKA University Venture CapitalSony Ventures CorporationTOHOKU University Venture PartnersUTEC

Nebulanebula.myAug 2018 · $4.3M

Nebula is a cloud gaming platform that lets users play PC games from any device, offering access to a library of games and high-performance gaming computers for a single subscription price.

Cloud ComputingConsumerGamingMountain View, US

Gordon Stitt(Executive Officer, Director)Devin Carlen(Director)Chris C. Kemp(Executive Officer, Director)

BoardLouis Toth(Director)inMark Leslie(Director)Peter Bell(Director)

Co-investorsAlpha Startups Pre-AcceleratorARCH Venture PartnersComcast VenturesFenbushi CapitalHemi Ventures, LlcHighland Capital Partners+5 more

Nebula Genomicsnebula.orgAug 2018 · $4.3M

Nebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA.

BiotechConsumerDigital Health

George Church(Founder)in

Co-investorsHemi Ventures, LlcHikma VenturesWindham Capital PartnersARCH Venture PartnersFenbushi CapitalKhosla Ventures+2 more

Rezeranodthera.comin𝕏Series A · Jun 2018 · $40M

NodThera develops clinical-stage small-molecule therapies targeting inflammation for cardiometabolic and neuroinflammatory diseases, including cardiovascular disease, metabolic dysfunction, and neuroinflammation.

BiotechHealthtech

Geoff McDonough(Executive Team / Board)inChris Guiffre(Executive Team)inAlan P. Watt(Executive Team)inJyothis George(Chief Medical Officer)inNick Clarke(Executive Team)in

Co-investors5AM VenturesEpidarex CapitalSanofi VenturesSofinnova Partners

Unisonunison.comin𝕏Jun 2018 · $40MNo public record

Unison offers home equity sharing products that let homeowners access the equity in their homes without selling or taking on debt, while giving institutional investors exposure to owner-occupied residential real estate.

FintechPropTech

Thomas Sponholtzin

Co-investorsCommerce VenturesThirdstream PartnersCiti Ventures

UNISONin-unison.comin𝕏Jun 2018 · $40M

Unison develops hardware and software tools for creative and productive computing.

AI & Machine LearningConsumerDeep TechDeveloper ToolsGamingHardwareSan Francisco, US

MichaelMaxime C PeroumalAbtin Khayatian(Product Engineer)Justin Lloyd(Principal Software Engineer)Mieszko Kruger(Principal Hardware Engineer)Michael Mayers(Principal Software Architect)

Co-investorsEQTGeneral CatalystLGFNFXLa FamigliaOlive Tree Capital+11 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Modis Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.